PNC Financial Services Group’s iBio IBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Hold
0
-$4 4751
2022
Q4
Hold
0
4755
2021
Q2
Sell
-4
Closed -$3K 4225
2021
Q1
$3K Hold
4
﹤0.01% 3905
2020
Q4
$2K Hold
4
﹤0.01% 3840
2020
Q3
$4K Hold
4
﹤0.01% 3711
2020
Q2
$4K Hold
4
﹤0.01% 3674
2020
Q1
$2K Buy
+4
New +$1.54K ﹤0.01% 3730

Other funds holding IBIO

PNC Financial Services Group's IBIO Position: Q1 2023 in Review

PNC Financial Services Group held its iBio (IBIO) position steady in Q1 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4751.

PNC Financial Services Group first reported a position in IBIO in Q1 2020 and has held it in 5 quarters since. The position peaked at $4K in Q3 2020. 29 funds tracked by Wall St. Rank hold IBIO as of Q1 2023.

  • PNC Financial Services Group held 0 shares of iBio worth $0 as of Q1 2023.
  • PNC Financial Services Group left its iBio share count unchanged in Q1 2023.
  • iBio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2023, its #4751 holding.
  • PNC Financial Services Group first reported a position in iBio in Q1 2020 and has held it in 5 quarters since.
  • PNC Financial Services Group's iBio position peaked at $4K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held iBio as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.